The Current Ratio as of December 2025 (TTM) for ArriVent BioPharma, Inc. Common Stock (AVBP) is 12.74

According to ArriVent BioPharma, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 12.74. This represents a change of -14.37% compared to the average of 14.88 of the last 4 quarters.

ArriVent BioPharma, Inc. Common Stock (AVBP) Historical Current Ratio (quarterly & annually)

How has AVBP Current Ratio performed in the past?

The mean historical Current Ratio of ArriVent BioPharma, Inc. Common Stock over the last ten years is 18.09. The current 12.74 Current Ratio has changed 6.94% with respect to the historical average. Over the past ten years (40 quarters), AVBP's Current Ratio was at its highest in in the March 2024 quarter at 32.82. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

ArriVent BioPharma, Inc. Common Stock (AVBP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ArriVent BioPharma, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ArriVent BioPharma, Inc. Common Stock (AVBP) Average Current Ratio

How has AVBP Current Ratio performed in the past?

The current Current Ratio of ArriVent BioPharma, Inc. Common Stock (AVBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ArriVent BioPharma, Inc. Common Stock (AVBP) Current Ratio vs. Peers

How is AVBP’s Current Ratio compared to its peers?

ArriVent BioPharma, Inc. Common Stock’s Current Ratio is greater than MeiraGTx Holdings plc (0.22), greater than Replimune Group, Inc. (6.94), less than Astria Therapeutics, Inc. (14.89), less than MBX Biosciences, Inc. Common Stock (32.95), greater than Ginkgo Bioworks Holdings, Inc. (4.39), greater than Iovance Biotherapeutics, Inc. (3.27), greater than Valneva SE (2.27), greater than Erasca, Inc. (11.04), greater than Arvinas, Inc. (5.70), greater than Day One Biopharmaceuticals, Inc. (8.68),

Build a custom stock screener for ArriVent BioPharma, Inc. Common Stock (AVBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ArriVent BioPharma, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ArriVent BioPharma, Inc. Common Stock (AVBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ArriVent BioPharma, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.